Back to AVTX
TCG Crossover Management, LLC → AVTX
TCG Crossover Management, LLC AVTX Position History
Avalo Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$46.3M
Q3 2026
Peak value
$55.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $8.8M |
| Q1 2026 | $11M |
| Q2 2026 | $55.8M |
| Q3 2026 | $46.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $46.3M | 3.02M | — | — |
| Q2 2026 | $55.8M | 3.02M | — | — |
| Q1 2026 | $11M | 738.4K | — | — |
| Q4 2025 | $8.8M | 483.0K | — | — |
Other funds holding AVTX
$66.7M
$64.2M
$59M
$58.5M
$55.3M
$53.4M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC